Financial News
All News about Gilead Sciences
![](https://mms.businesswire.com/media/20230720298935/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Via Talk Markets
![](https://mms.businesswire.com/media/20230721916957/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230720619841/en/1846139/5/CDAF_Logo_Horizontal_1686x800.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Peering Into Gilead Sciences's Recent Short Interest
July 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230719021635/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://ml.globenewswire.com/media/26c37367-6d70-48af-b8d2-e9ca1c399cb6/small/cdaf-logo-horizontal-211x100-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/740095/analyst-on-wall-street-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Price Over Earnings Overview: Gilead Sciences
July 17, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/nasdaq1600.jpg)
![](https://mms.businesswire.com/media/20230719263471/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://g.foolcdn.com/editorial/images/739754/pharmacist-talking-to-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/18/screenshot_2023-07-18_at_5.32.41_pm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/739726/gettyimages-528570142.jpg)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](https://mms.businesswire.com/media/20230714408028/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/14/remdesivir.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230713562695/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230713072449_gilead-boosts-biotech-footprint-with-stakes-in-all.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230712120806_3-biotech-stocks-to-buy-for-long-term-gains.jpg)
![](https://mms.businesswire.com/media/20230713396651/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/tech1600e.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/10/screenshot_2023-07-10_at_6.42.30_pm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/738832/doctor-with-patient-talking.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230705112152_1-billion-deal-for-moderna-to-expand-product-pipel.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.